Mumbai, Baltimore, November 08, 2023: Global pharma major Lupin Limited (Lupin) today announced the launch of Rocuronium Bromide Injection, 50 mg/5 mL (10 mg/mL) and 100 mg/10 mL (10 mg/mL) Multiple-Dose Vials, after Lupin’s alliance partner Caplin Steriles Limited (Caplin) received an approval for its ANDA from the United States…Read More
Lupin November 8 2023 Lupin Launches Rocuronium Bromide Injection in the United States
